Vivani Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.75	16.23	18.35	20.65	45.08	2.18
Cash & Short-Term Investments	19.75	16.23	18.35	20.65	45.08	2.18
Cash Growth	51.82%	-11.55%	-11.15%	-54.18%	1969.61%	-31.45%
Accounts Receivable	0.01	-	-	-	-	-
Other Receivables	0.69	0.65	0.25	-	-	-
Total Trade Receivables	0.7	0.65	0.25	-	-	-
Other Current Assets	1.1	1.01	1.84	2.41	2.45	0.29
Total Current Assets	21.55	17.9	20.44	23.06	47.53	2.47
Net Property, Plant & Equipment	19.37	20.11	19.65	21.35	1.96	2.78
Other Long-Term Assets	1.44	1.39	1.47	1.39	1.64	0.2
Total Assets	42.35	39.39	41.56	45.8	51.13	5.45
Accounts Payable	1.47	1.03	0.82	0.54	1.18	0.28
Accrued Expenses	3.53	3.78	3.82	3.8	4.69	0.9
Current Portion of Leases	1.78	1.79	1.35	1.38	0.96	0.91
Total Current Liabilities	6.78	6.6	5.99	5.72	6.82	2.09
Long-Term Leases	16.49	17.06	17.97	19.31	-	0.9
Total Long-Term Liabilities	16.49	17.06	17.97	19.31	-	0.9
Total Liabilities	23.27	23.66	23.95	25.04	6.82	2.99
Common Stock	0.01	0.01	0.01	0.01	0.01	54.65
Additional Paid-in Capital	174.36	164.23	139.48	119.05	117.05	6.71
Accumulated Other Comprehensive Income	0.03	0.03	0.05	0.14	0.04	-
Retained Earnings	-155.31	-148.53	-121.92	-98.44	-72.79	-58.9
Shareholders' Equity	19.09	15.73	17.61	20.76	44.31	2.47
Total Liabilities & Equity	42.35	39.39	41.56	45.8	51.13	5.45
Total Debt	18.28	18.86	19.31	20.7	0.96	1.81
Net Cash (Debt)	1.47	-2.62	-0.96	-0.04	44.12	0.37
Net Cash Growth	-	-	-	-	11954.92%	-62.54%
Net Cash Per Share	0.02	-0.04	-0.02	-0.00	1.15	0.01
Book Value	19.09	15.73	17.61	20.76	44.31	2.47
Book Value Per Share	0.28	0.25	0.32	0.41	1.16	0.07
Tangible Book Value	19.09	15.73	17.61	20.76	44.31	2.47
Tangible Book Value Per Share	0.28	0.25	0.32	0.41	1.16	0.07

SEC Filings: 10-K · 10-Q